ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $39,000 | -15.2% | 2,085 | -46.9% | 0.00% | – |
Q2 2019 | $46,000 | -11.5% | 3,930 | -24.9% | 0.00% | – |
Q4 2018 | $52,000 | -40.2% | 5,234 | 0.0% | 0.00% | – |
Q3 2018 | $87,000 | +4.8% | 5,234 | 0.0% | 0.00% | – |
Q2 2018 | $83,000 | +23.9% | 5,234 | 0.0% | 0.00% | – |
Q1 2018 | $67,000 | +11.7% | 5,234 | 0.0% | 0.00% | – |
Q4 2017 | $60,000 | 0.0% | 5,234 | 0.0% | 0.00% | – |
Q3 2017 | $60,000 | 0.0% | 5,234 | 0.0% | 0.00% | – |
Q2 2017 | $60,000 | -44.4% | 5,234 | 0.0% | 0.00% | – |
Q1 2017 | $108,000 | -0.9% | 5,234 | 0.0% | 0.00% | – |
Q4 2016 | $109,000 | -68.1% | 5,234 | -50.0% | 0.00% | – |
Q3 2016 | $342,000 | +163.1% | 10,468 | +100.0% | 0.00% | – |
Q2 2016 | $130,000 | +97.0% | 5,234 | +93.9% | 0.00% | – |
Q1 2016 | $66,000 | -25.8% | 2,700 | 0.0% | 0.00% | – |
Q4 2015 | $89,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
Q3 2015 | $89,000 | -37.3% | 2,700 | 0.0% | 0.00% | – |
Q2 2015 | $142,000 | – | 2,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |